๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Tissue-type plasminogen activator: Intracoronary applications

โœ Scribed by Tiefenbrunn, Alan J.

Publisher
John Wiley and Sons
Year
1990
Tongue
English
Weight
919 KB
Volume
19
Category
Article
ISSN
0098-6569

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Effect of oral defibrotide on tissue-pla
Effect of oral defibrotide on tissue-plasminogen activator and tissue-plasminogen activator inhibitor balance
โœ F. Violi; D. Ferro; M. Saliola; C. Quintarelli; S. Basili; F. Balsano ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› Springer ๐ŸŒ English โš– 491 KB

Defibrotide, a polydeoxyribonucleotide of mammalian origin, has been shown to reduce the blood level of the plasminogen activator inhibitor, and so to increase the activity of tissue plasminogen activator without any adverse effect. A randomized, double-blind, placebo-controlled study has been done

Activation of coagulation factor VII by
Activation of coagulation factor VII by tissue-type plasminogen activator
โœ Tsujioka, Hiroshi; Suehiro, Akira; Kakishita, Eizo ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 90 KB

To investigate the effect of tissue-type plasminogen activator (t-PA) on blood coagulation, we examined the effects of the addition of t-PA to normal pool plasma (NPP) on clotting times such as diluted prothrombin time (PT) and kaolin clotting time (KCT). The diluted PT but not the KCT was significa